NVOS Novo Integrated Sciences Inc
10,563
$0.465
$0.002
(0.43%)
| Watchers | 10,563 |
| 52-Wk Low | $0.416 |
| 52-Wk High | $5.38 |
| Market Cap | $7.85M |
| Volume | 520,405.00 |
| 52-Wk High | $5.38 |
| 52-Wk Low | $0.416 |
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial ResultsBusiness Wire • about 1 month ago
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the Company or Novo), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple...
Share to Feed
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo) announced today the Company has entered into a securities purchase agreement, dated April 5, 2024, with Streeterville Capital, LLC...
CRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICA CRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICA PR Newswire WEST PALM BEACH, Fla., April 11, 2024 WEST PALM BEACH, Fla., April...
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo), today provides an update with respect to certain actions and events, as follows: Purchase and Sale Agreement Ophir Collection: As...
Novo Integrated Sciences (NVOS) has released an update. Novo Integrated Sciences, Inc. has proudly announced a new partnership with Futura Surgicar...
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo), and Clinical Consultants International, LLC (CCI), a Novo wholly-owned subsidiary, today announced the signing of a Consulting...
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo) announces today the Company has received a Limited Waiver, specific to Section 3, of the previously disclosed Securities Purchase...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo) announces today Mr. Robert Oliva has been appointed as the Companys new President. Mr. Oliva succeeds Mr. Christopher David, who...
Novo Integrated Sciences (NASDAQ:NVOS Get Free Report) and RH N-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY Get Free Report) are both medical companies, but which is the better...